Hanjoon Alex Kim serves as Executive at STANDARD BIOTOOLS INC., where they oversee executive responsibilities. Since joining the company, Hanjoon Alex Kim has executed 8 insider transactions totaling $0, demonstrating a balanced approach to their equity position. Their most recent transaction on Feb 23, 2026 involved selling 12,740 shares valued at $14.7K.
Hanjoon Alex Kim currently holds 2,407,346 shares of STANDARD BIOTOOLS INC. (LAB), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Hanjoon Alex Kim has been a net neutral trader of LAB stock. They have purchased $0 and sold $0 worth of shares.
Hanjoon Alex Kim's most recent insider trade was on Feb 23, 2026, when they sold 12,740 shares at $1.15 per share.
Get notified when new Form 4 filings are submitted
| $1.28 |
| Discretionary |
| Aug 20, 2025 | LAB | $16.2K | Payment | 12,739 | $1.27 | Discretionary |
| Aug 1, 2025 | LAB | $0 | Award | 1,500,000 | $N/A | Discretionary |
| May 20, 2024 | LAB | $0 | Award | 333,333 | $N/A | Discretionary |
| Apr 5, 2024 | LAB | $0 | Award | 70,702 | $N/A | Discretionary |
| Apr 4, 2024 | LAB | $0 | Option Exercise | 70,183 | $N/A | Discretionary |
| Apr 4, 2023 | LAB | $0 | Option Exercise | 70,183 | $N/A | Discretionary |